| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10172146 | Respiratory Investigation | 2013 | 8 Pages |
Abstract
These results suggest that modification of ICS therapy can suppress residual FENO elevation, and that reduction in FENO levels is associated with improvement in airflow limitation. However, steroid-resistance mechanisms may exist in some asthmatic patients with sustained FENO elevations.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology and Microbiology (General)
Authors
Tsunahiko Hirano, Kazuto Matsunaga, Hisatoshi Sugiura, Yoshiaki Minakata, Akira Koarai, Keiichiro Akamatsu, Tomohiro Ichikawa, Kanako Furukawa, Masakazu Ichinose,